LRI Investments LLC Sells 4,445 Shares of Kenvue Inc. $KVUE

LRI Investments LLC trimmed its stake in shares of Kenvue Inc. (NYSE:KVUE) by 26.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,648 shares of the company’s stock after selling 4,445 shares during the quarter. LRI Investments LLC’s holdings in Kenvue were worth $265,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in KVUE. Evergreen Wealth Solutions LLC increased its stake in Kenvue by 2.6% in the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock worth $402,000 after acquiring an additional 432 shares during the last quarter. Scott & Selber Inc. increased its stake in Kenvue by 0.4% in the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company’s stock worth $2,557,000 after acquiring an additional 475 shares during the last quarter. Wealth Alliance LLC increased its stake in Kenvue by 1.6% in the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after acquiring an additional 486 shares during the last quarter. Everett Harris & Co. CA increased its stake in Kenvue by 1.4% in the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after acquiring an additional 500 shares during the last quarter. Finally, Proffitt & Goodson Inc. increased its stake in Kenvue by 8.2% in the 2nd quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock worth $143,000 after acquiring an additional 517 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Evercore ISI decreased their target price on Kenvue from $23.00 to $18.00 and set an “in-line” rating on the stock in a research note on Tuesday, September 23rd. Rothschild Redb upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Barclays reduced their price objective on Kenvue from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Kenvue in a research report on Saturday, September 27th. Finally, JPMorgan Chase & Co. reduced their price objective on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $21.18.

Kenvue Price Performance

Shares of KVUE opened at $16.68 on Monday. The firm has a fifty day moving average price of $19.15 and a 200 day moving average price of $21.31. Kenvue Inc. has a 1-year low of $15.47 and a 1-year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The stock has a market cap of $32.00 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 2.39 and a beta of 0.72.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The business had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same period in the prior year, the company earned $0.32 earnings per share. The business’s revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.0%. Kenvue’s dividend payout ratio is currently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.